<div id="readability-page-1">09:10 AM EST, 12/24/2025 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) said Wednesday that S&amp;P Global Ratings (SPGI) has upgraded its long-term issuer credit rating to BB+ from BB.The company also said Moody's (MCO) affirmed its B1a rating and revised its outlook to positive from stable.Teva said the ratings decisions were based on its improvement in operating performance and its debt reduction policies, as well as momentum in its branded franchises and product launches.Shares of the pharmaceutical company were up 1% pre-bell. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

梯瓦制药

梯瓦制药的信用评级被标准普尔上调至 BB+，穆迪将其展望调整为积极，原因是运营表现改善、债务减少以及产品发布势头强劲。股价在开盘前上涨了 1%

梯瓦制药的信用评级被标普上调，穆迪上调其展望